Regulation & market

503A pharmacy

A traditional compounding pharmacy, compounding for individually identified patients against a prescription.

In plain terms

503A facilities are overseen primarily by state boards of pharmacy and are exempt from certain federal requirements — including the requirement to follow GMP — on the condition that they compound patient-specific preparations rather than manufacture at scale.

Guides that use this term

Are peptides legal? What the FDA actually says

BPC-157, TB-500, CJC-1295 and ipamorelin: what the FDA has actually published about each, why “removed from Category 2” does not mean cleared, and what is still unlawful to compound.

Compounded semaglutide and tirzepatide: what changed

The shortages ended, and with them the enforcement discretion that allowed mass compounding of semaglutide and tirzepatide. What FDA actually said, with the dates, and what remains permitted.

Sources

FDA — Compounding and the FDA: Questions and Answers

Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations.